Back to top

Jefferies Keeps Their Buy Rating on Praxis Precision Medicines (PRAX)

Jefferies analyst Andrew Tsai maintained a Buy rating on Praxis Precision Medicines today and set a price target of $550.00. Tsai covers the Health...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Praxis Precision Medicines, Inc. (PRAX)